Skip to main content
Menu
Hub
Open Hub
About the Hub
Announcements
For Media
Subscribe to the newsletter
Explore by Topic
Arts+Culture
Athletics
Health
Politics+Society
Science+Technology
Student Life
University News
Voices+Opinion
Events
At Work
Open At Work
About Hub at Work
Classifieds
Gazette Archive
Explore by Topic
News+Info
Benefits+Perks
Health+Wellness
Tools+Tech
Happenings
Johns Hopkins Magazine
Open Johns Hopkins Magazine
About the Magazine
Past Issues
Contact
Giving
Subscribe to the Magazine
jhu.edu
Search
Archived articles
bloomberg-kimmel institute
Cancer research
Immunotherapy better than chemo at treating rare form of skin cancer
Published
March 5, 2019
Drug marketed as Keytruda shown to be more effective than chemotherapy at treating Merkel cell carcinoma
Cancer research
Suppressing YAP protein gives immunotherapy a boost
Published
Aug 7, 2018
In mouse study, researchers find that turning off YAP protein in regulatory T-cells enhances anti-tumor immune response
Immunotherapy
One-two punch for ovarian cancer
Published
Dec 5, 2017
Mouse study finds that combination immunotherapy could improve ovarian cancer treatment
Cancer research
FDA approves cancer drug for personalized immunotherapy approach
Published
May 25, 2017
Drug was developed from 30 years of basic research at Johns Hopkins
Cancer research
Immune to immunotherapy
Published
Jan 6, 2017
Johns Hopkins scientists zero in on process that helps cancer cells evade immune system attacks during immunotherapy treatment
Cancer research
A landmark year for immunotherapy
Published
Dec 28, 2016
Bloomberg–Kimmel Institute for Cancer Immunotherapy director recaps five major research findings from 2016
Cancer research
How immunotherapy works
Published
Dec 20, 2016
Treatment is like releasing the immune system's 'parking brake,' JHU oncologist Drew Pardoll says
/ The Washington Post
Cancer research
A personalized approach for immunotherapy
Published
Nov 10, 2016
Collaboration with Bristol-Myers Squibb includes several clinical trials led by scientists at Bloomberg-Kimmel Institute